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Abstract 
Background: Encrustation of urinary catheters is a frequent problem in patients with long-term indwelling 
catheters colonised with urease-positive bacteria such as Proteus mirabilis. Catheter blockage may follow 
catheter encrustation, potentially leading to systemic infection. Prevention of encrustation is difficult and 
avoidance of recurrence often unsuccessful. One possible preventative strategy is to use a catheter with an 
antimicrobial surface and development and assessment of such a surface was the aim of this research. 
Methods: Initial experiments assessed the antimicrobial activity of silicone impregnated with plant-derived 
antimicrobials and triclosan using agar diffusion. The longevity of activity of each antimicrobial silicone 
was examined over a period of 11 weeks following soaking individual pieces of antimicrobial silicone in 
an artificial urine solution before using agar diffusion to test remaining antimicrobial activity. Live/Dead 
staining of bacteria colonising the surface of each antimicrobial silicone was employed to determine the 
bactericidal properties of each antimicrobial silicone. Selected antimicrobial silicones were subsequently 
evaluated for their ability to prevent catheter encrustation in an in vitro bladder model. 
Results: Results showed that antimicrobial activity was obtained using 1% triclosan-impregnated silicone 
and that this antimicrobial activity was long-lasting (up to 11 weeks). Use of a dip coat silicone formulation, 
containing 0.2% triclosan, proved effective at delaying catheter encrustation with P. mirabilis metabolites 
in vitro. In 8 out of 13 independent experiments using dip-coated catheters, no catheter blockage occurred 
over 7 days, whilst all control catheters blocked during this period. Only on one occasion was delayed 
encrustation not evident with the treated catheters. 
Conclusions: In summary, a dip-coat silicone containing triclosan proved effective in preventing in vitro
catheter encrustation caused by P. mirabilis infection. Further studies with triclosan silicone dip coat 
formulation are warranted, including those that investigate potential host cell toxicity and long-term 
benefits following its application to indwelling urinary catheters in clinical settings.
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Introduction
Catheter associated-urinary tract infections (CA-UTIs) are the 
most frequently encountered hospital acquired infections, 
with 70-80% involving an indwelling urinary catheter [1]. The 
widely used Foley catheter predisposes patients to CA-UTIs 
as it disrupts the normal protective effect of urinary flow and 
provides a conduit for pathogens to the bladder that ‘by-passes’ 
the natural antimicrobial mechanisms of the urethral mucosa. 
Once the bladder is colonised, the inflated catheter retention 
balloon ensures that the bladder does not completely empty, 
resulting in the retention of contaminated urine in the bladder 
[2].
Potential consequences of CA-UTI are numerous, and include 
pyelonephritis, septicaemia, bladder stone development, 
bacteraemia, endotoxic shock, and catheter encrustation 
[3]. Several microbial species, including Escherichia coli and 
Microbiology Discovery
ISSN 2052-6180 | Volume 3 | Article 1 
*Correspondence: JordanRP@cardi.ac.uk
1School of Dentistry, College of Biomedical and Life Sciences, Cardi University, Heath Park, Cardi, CF14 4XY, Wales, UK.
2School of Healthcare Science, Manchester Metropolitan University, Manchester, M1 5GD, UK.
3MBI (WALES) Ltd./Technovent Ltd., Unit 5, Kingsway Buildings, Bridgend Industrial Estate, Bridgend CF31 3YH, Wales, UK.
4School of Biosciences, Main Building, Cardi University, Museum Avenue, Cardi CF10 3TL, Wales, UK.
CrossMark
← Click for updates
Jordan et al. Microbiology Discovery 2015, 
http://www.hoajonline.com/journals/pdf/2052-6180-3-1.pdf
2
doi: 10.7243/2052-6180-3-1
Pseudomonas aeruginosa can cause CA-UTIs, although it 
is infection by urease producing bacteria and particularly 
Proteus mirabilis that are frequently most problematic [4]. 
Proteus mirabilis produces a potent urease that hydrolyses urea 
leading to formation of ammonium and carbonate ions, which 
increase urinary pH. In alkaline urine, magnesium and calcium 
phosphates precipitate and impede urinary flow through the 
catheter [5]. Management of urinary catheter encrustation 
in long-term indwelling catheters is difficult, and no single 
effective prevention strategy is currently recognised [6].
The emergence and spread of antibiotic resistant micro-
organisms had driven the need to find new antimicrobial 
agents and in recent years, this has led to considerable interest 
in the use of natural antimicrobials, which, by often targeting 
multiple microbial sites, are associated with reduced incidence 
of resistance [7]. Recently we have identified several plant-
derived antimicrobial agents with activity against P. mirabilis [8]. 
These studies highlighted the antimicrobial effects of eugenol 
(an essential oil extracted from clove oil), terpinen-4-ol and 
cineole (components of tea tree oil) against P. mirabilis. Triclosan 
(2,4,4’-trichloro-2’-hydroxydiphenyl ether), whilst not a natural 
antimicrobial agent, has been used as a biocide in numerous 
industrial and household products [9] and importantly, this 
agent is also highly effective against P. mirabilis [10] and as 
such triclosan was also evaluated in this investigation.
The aim of this present study was to use the natural 
antimicrobials, eugenol and terpinen-4-ol, in addition to 
triclosan, to develop novel antimicrobial silicone formulations 
that could prevent catheter encrustation. Constructed 
antimicrobial silicones were applied as a material insert or 
a ‘dip coat’ to Foley catheters and assessed for their ability 
to delay or prevent in vitro catheter encrustation following P. 
mirabilis infection. This study found that a dip coat silicone 
containing 0.2% triclosan was effective at preventing catheter 
encrustation in all but one test catheter and as such, further 
investigation, including host cell toxicity and effectiveness 
in a clinical setting is warranted.
Materials and methods 
Bacterial strains and culture conditions
Bacterial isolates associated with urinary tract infection (Table 1) 
were cultured on Cysteine Lactose Electrolyte Deficient (CLED; 
Oxoid, Basingstoke, United Kingdom) agar at 37°C. Artificial 
urine was used as a liquid culture medium, as previously 
described with incorporation of Tryptone Soya Broth (TSB) at 
1 g/L [20,21]. Mueller-Hinton Broth (MHB; Oxoid) and Iso-
Sensitest Agar (ISO; Oxoid) were used for antimicrobial asse-
ssment by zone of inhibition testing.
Manufacture of antimicrobial silicone material
Stock antimicrobial solutions were 10% (w/w) triclosan (Sigma-
Aldrich, Poole, United Kingdom) in 2-propanol (Sigma-Aldrich), 
10% (w/w) eugenol (Sigma-Aldrich) and 5% (w/w) terpinen-
4-ol (Sigma-Aldrich), both in acetone. Solvent only controls 
Isolate Original source of 
isolate
Reference
Proteus mirabilis NCTC 
11938*
Putreed meat [11]
P. mirabilis B2 Catheter biolm [12]
P. mirabilis RB6 Catheter biolm [13] 
P. mirabilis NSM6 Clinical isolate of an 
encrusted catheter of a 
patient undergoing long 
term catheterisation
[14] 
P. mirabilis NCTC 13376/ 
ATCC® 14153™
Reference strain n/a
P. mirabilis HI4320-wild 
type
Urine of a long-term-
catheterised elderly 
patient with signicant 
bacteriuria
[15,16] 
P. mirabilis NP6 Urine of a patient at a 
nursing home
[17] 
P. mirabilis RB22 Clinical isolate n/a
P. mirabilis urease neg 2 Clinical isolate n/a
Proteus vulgaris H2V Clinical isolate n/a
P. vulgaris NSM19 Clinical isolate [18] 
P. vulgaris SDM2 Catheter biolm [13]
Providencia rettgeri SDM1 Catheter biolm [13]
Providencia stuartii NSM40 Indwelling catheter of 
long term catheterised 
patient
[19] 
Escherichia coli NCTC 12923 Reference strain n/a
Pseudomonas aeruginosa
SDM5
Clinical isolate n/a
Ps. aeruginosa NCTC 10662 Reference strain n/a
Staphylococcus aureus P10 
6/9
Catheter biolm [13]
Table 1. Bacterial species and strains used in this study.
*Type strain
were also tested. Polydimethylsiloxanes of various molecular 
weight (Silanes & Silicones Ltd., Manchester, United Kingdom), 
silica filler (hydrophobic Gelest filler; Silanes & Silicones Ltd.) 
and hydrophilic Cabosil filler (Sigma-Aldrich) were mixed for 
at least 1 h. The developed ‘Base’ was then used to prepare 
two component parts (parts A and B). Part A consisted of Base, 
platinum catalyst (Silanes & Silicones Ltd.) and either the test 
antimicrobial or its control solvent. Part B consisted of Base, 
cross linker (Silanes & Silicones Ltd.) and either antimicrobial 
agent or control solvent. Equal quantities of parts A and B 
were mixed and cured for 10-15 min at 90°C in an appropriate 
mould, resulting in a final concentration of 1% triclosan, 1% 
eugenol or 0.5% terpinen-4-ol solution in the cured silicone. 
Once cooled, the biomaterial was cut into 1-cm2 squares and 
autoclaved. In addition, a triclosan containing silicone dip coat 
was also prepared using parts A and B. Parts A and B were 
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diluted separately at a ratio of 20% solid silicone formulation 
to 80% 1cst fluid (diluent) before equal amounts of diluted 
parts A and B were mixed resulting in a final concentration 
of 0.2% triclosan in the silicone dip coat. This silicone dip was 
used to coat all-silicone (100%) Foley catheters (size 14 Ch; C. 
R. Bard, Inc., Crawley, United Kingdom) by immersion in the 
formulation for 5 min, before air-drying for 12 h.
Assessment of antimicrobial activity of developed silicone
Bacteria maintained on CLED agar were sub-cultured in 10 
ml of MHB and cultured for 16 h at 37°C with gentle rotation 
(100 rev/min). Test bacteria were spread-plated on ISO agar 
and incubated for 3.5 h at 37°C. A silicone square (1 cm2) con-
taining test antimicrobial or solvent control was placed in the 
centre of the agar. After incubation at 37°C for 16 h, zones of 
growth inhibition were measured. Each antimicrobial mate-
rial was tested in triplicate. Data from the zone of inhibition 
experiments were correlated and graphically depicted using 
GraphPad Prism® Software Version 4.00 (GraphPad Software 
Inc., La Jolla, USA).
To determine persistence of antimicrobial activity, silicone 
squares (10 mm×10 mm×5 mm containing 1% triclosan) were 
immersed in 1 L of artificial urine at 37°C. At weekly intervals, 
specimens were removed and tested for antimicrobial activity 
against P. mirabilis NCTC 11938 using zone of inhibition test-
ing. The artificial urine was replenished weekly for 11 weeks. 
Live/Dead staining of bacteria on antimicrobial bio-
materials
Proteus mirabilis NCTC 11938 was cultured for 4 h at 37°C in 
artificial urine. A portion of the culture was stained using LIVE/
DEAD® BacLight™ Bacterial Viability Kit (Molecular Probes 
Europe BV, The Netherlands) according to the manufacturer’s 
instructions. A 10-μl volume of the stained bacteria was then 
deposited on the surface of the silicone and overlaid with a 
cover slip before being observed using time-lapse confocal 
microscopy over 24 h. 
Prevention of urinary catheter encrustation by antimi-
crobial silicones 
Cylinders (5 mm height) of solid silicone were constructed 
using cork-borers (Cole-Parmer Instrument Co. Ltd, United 
Kingdom). A single cylinder was located into the fluted part 
of the lumen of an all-silicone (100%) Foley catheter prior to 
autoclaving. Test solid silicone contained a final concentration 
of 1% triclosan and control catheters contained solvent alone 
(2-propanol). Additional catheters were coated, intra- and 
extra-luminally, using liquid silicone formulation containing 
a final concentration of 0.2% triclosan and control catheters 
contained solvent (2-propanol) alone. 
Test catheters were located within an in vitro bladder model 
(Figure 1; [21]) and the retention balloon inflated with 10 mL of 
sterile water. The catheter was connected to a drainage tube 
and bag in the standard way. The distance from the bottom 
Figure 1. Schematic representation of the in vitro 
bladder model [21] used in the current study.
of the bladder chamber to the top of the drainage bag was 
50 cm and a loop (outside radius 10 cm) was introduced into 
the drainage system.
Artificial urine was added to the bladder chamber at 0.4 ml/
min via a peristaltic pump until it filled the bladder chamber 
to just below the catheter eyehole. Delivery of artificial urine 
to the bladder chamber was stopped and the drainage tube 
and bag completely emptied of artificial urine before inocu-
lating the drainage bag (through the drainage tap) with 10 
mL of a 4-h artificial urine culture of P. mirabilis NCTC 11938. 
Contamination events were performed four times per day and 
involved raising the drainage bag, to create a reverse flow of 
contaminated urine, to a defined level in the drainage tube and 
holding the contaminated urine at this level for 30 s. Where 
catheters contained a solid silicone insert, the contamination 
level in the drainage tube was defined as the base of the in-
serted silicone material. Where the catheters were dip coated, 
the contamination level was defined at a 1 cm mark on the 
drainage tube, below the connection point of the drainage 
tube and the catheter (Figure 1). Supply of artificial urine was 
recommenced after each contamination event.
The models were run for a maximum of 7 days, or until the 
  Proteus 
  infected
  urine
10 cm
1 cm
        Urine at
        0.4 ml/min
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catheters blocked. Catheters were defined as blocked when 
artificial urine began to collect in the bladder chamber, above 
the level of the catheter eyehole. Time taken for catheters to 
block was determined based on volume of urine removed 
from the drainage bags. Each experiment comprised of 3 
‘test’ catheters and two ‘control’ catheters. Experiments were 
repeated on five separate occasions. 
Results
Antimicrobial activity of novel silicone materials
Inhibition of growth based on agar diffusion was evident only 
with 1% triclosan-containing silicone, which was effec-
tive against 15 of the 18 test isolates (Providencia rettgeri
SDM1, Pseudomonas aeruginosa SDM5 and Ps. aeruginosa 
NCTC 10662 were not susceptible; Figure 2). No antimicro-
bial activity was evident using eugenol or terpinen-4-ol 
incorporated into silicone, despite having previously dem-
onstrated activity outside silicone against these bacterial 
strains [8]. Eugenol, when tested in its acetone diluent and 
not in silicone, retained its previously shown antibacterial 
effect, however, terpinen-4-ol, in the presence of acetone 
Figure 2. Antimicrobial activity of solid silicone containing 
triclosan against test bacterial strains.
Zones of inhibition of growth of selected bacterial strains 
involved in CA-UTI by a solid silicone formulation containing 
a nal concentration of 1% triclosan. e zone of inhibition 
of growth of each isolate was measured in mm and the value 
shown above includes the 10 mm measurement of the silicone 
square. All isolates tested were susceptible to 1% triclosan 
in solid silicone formulation except Providencia rettgeri
SDM1, Pseudomonas aeruginosa SDM5 and Ps. aeruginosa
NCTC 10662. e graph represents the Mean and Standard 
Error of the Mean from duplicate readings taken when each 
antimicrobial material was tested in triplicate.
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solvent, lost its antibacterial activity (results not shown). 
Live/dead staining of P. mirabilis NCTC 11938 on antimicrobi-
al silicones was undertaken to assess whether antimicrobial ef-
fects were associated with the silicone surface only, as previous 
zones of inhibition experiments would have required release 
of the agent into the agar. In these studies, the time to kill 
>95% of P. mirabilis NCTC 11938 deposited on the antimicro-
bial silicones was assessed in 24-h time course experiments. 
After 12 min, >95% of P. mirabilis NCTC 11938 were killed on 
silicone containing 1% triclosan. Conversely, after 24 h, >95% 
of P. mirabilis NCTC 11938 remained alive on eugenol- and 
terpinen-4-ol-containing silicone (Figure 3).
Figure 3. Live/Dead® staining of Proteus mirabilis NCTC 
11938 aer 24 h exposure to various solid silicone 
formulations.
Micrographs of Live/Dead stained Proteus mirabilis NCTC 
11938 following 24-h exposure to solid silicone formulations 
A: control silicone containing solvent alone, B: triclosan-
containing silicone, C: eugenol-containing silicone, D: terpinen-
4-ol-containing silicone. Live bacteria stain green and dead 
bacteria stain red. Over 95% of Live/Dead stained P. mirabilis
NCTC 11938 were alive following 24-h exposure to solid 
silicone formulation containing solvent alone (A), eugenol-
containing silicone (1%) (C) and terpinen-4-ol-containing 
silicone (0.5%) (D). Conversely, all P. mirabilis NCTC 11938 
were dead following 24-h exposure to solid silicone formulation 
containing 1% triclosan (B). 
As catheters can remain in place for up to 11 weeks, persistence 
of antimicrobial activity of solid silicone containing 1% triclosan 
was determined by immersing samples (10 mm×10 mm×5 
mm squares) in artificial urine, which was replaced at weekly 
intervals. The antimicrobial effect of the triclosan containing 
silicone was retained over this period, despite a gradual 
reduction in the size of the zone of inhibition of growth of 
P. mirabilis NCTC 11834 from week 0 (29 mm zone including 
10 mm silicone square) to week 11 (15 mm zone including 
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10 mm silicone square) (Figure 4). 
Prevention of urinary catheter encrustation by triclosan 
containing silicone
Where a solid triclosan silicone insert was used, out of 8 test 
catheters, only one showed delayed encrustation compared 
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Figure 4. Antimicrobial activity of various solid silicone 
formulations against Proteus mirabilis NCTC11938 over a 
period of 11 weeks.
ree solid silicone squares (10 mm×10 mm×5 mm) of each 
silicone formulation were tested for antimicrobial activity 
at weekly intervals and results were recorded in duplicate 
for each solid silicone square. e diameter of the zone of 
inhibition of growth of Proteus mirabilis NCTC 11938 was 
measured in mm and included the width of the silicone 
square (10 mm). A decrease in the zone of inhibition can 
be seen for each silicone formulation except for triclosan 
containing silicone formulation where the zone of inhibition 
increased at week 9 and week 10. Testing of eugenol 
containing silicone formulation, terpinen-4-ol containing 
silicone formulation and the acetone containing control were 
discontinued aer week 4 due to no zone of inhibition being 
observed from week 2 onwards.
Catheter type Results of  
Experiment 1
Results of  
Experiment 2
Results of  
Experiment 3
Results of  
Experiment 4
Results of  
Experiment 5
Test 150   132 >168   160   140
Test 156 >168 >168 >168 >168
Test No model   No model >168 >168 >168
Control 108   138   105   59    112
Control No model   No model   97   87    95
Table 2. Time (h) to blockage of catheters with triclosan-containing silicone dip coat (test) or the 
relevant solvent (control).
Five separate experiments containing 5 catheter models each were conducted to determine the 
time, in hours, to blockage of catheters dip-coated in liquid silicone formulation containing 
either triclosan (at a nal concentration of 0.2%) (test), or solvent alone (control). In experiment 
1 and 2, results for only three catheter models were recorded due to leakage of two of the bladder 
models meaning time to blockage could not be accurately determined. Results indicating >168 h, 
dene dip-coated catheters that did not block for the duration for the experiment.
to their controls and one test catheter did not block at all (data 
not shown). Importantly, however, using a triclosan containing 
liquid dip coat silicone formulation, a notable delay in time 
to blockage was evident compared with controls (dip coat 
containing solvent alone). In the case of 13 test catheters, 12 
exhibited delayed encrustation compared to controls, and 8 
of these did not block over the 7-day duration of the experi-
ment (Table 2). 
Discussion
CA-UTIs are a major problem throughout the world. A key 
factor in individuals who have long-term indwelling catheters 
is contamination and infection by the urinary pathogen, P. 
mirabilis. Proteus mirabilis is not only able to rapidly migrate 
along the material of catheter surfaces to contaminate the 
bladder, it also generates a highly potent urease enzyme. 
Urease metabolises urea to produce ammonia, which, in 
a hydrated environment produces hydroxyl ions leading 
to elevated urine pH. The potential effect of alkaline urine 
is subsequent crystallisation of magnesium and calcium 
phosphates leading to encrustation and catheter blockage 
[5]. Catheter blockage is clinically important, as not only will 
the resulting bladder distension be painful for the patient, but 
a blocked catheter also increases the risk of serious clinical 
complications including septicaemia and pyelonephritis [3]. 
Management of urinary catheter encrustation is difficult, 
and occurrence is both unpredictable and extremely hard to 
prevent with existing strategies [6]. Most often, the approach 
used is catheter replacement once blockage has occurred 
[22]. Unfortunately, such treatment is often unsuccessful 
with frequent recurrence of blockage evident [23]. Prophy-
lactic antibiotic use to prevent recurrence is not ideal due 
to the potential promotion of antibiotic resistance [24-26]. 
One possible approach is to employ catheter materials that 
incorporate an antimicrobial agent that is either gradually 
released to the surface to inhibit colonisation or is utilised 
as an external catheter coating.
Previously, we have demonstrated the effectiveness of 
several antimicrobial agents against urinary tract pathogens 
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including P. mirabilis. These agents included natural compounds 
from plant extracts (tea tree oil, terpinen-4-ol, cineole, and 
eugenol [8]) and the widely used antimicrobial, triclosan [10]. 
Following this previous research, the aim of this study was 
to develop an antimicrobial insert or a coating that would 
theoretically prevent catheter encrustation caused by P. 
mirabilis infection. 
Results showed that whilst several plant-derived antimi-
crobial agents had demonstrated previous in vitro activity 
against selected bacterial isolates [8], their incorporation into 
silicone or solvent, negated antimicrobial effects. Significantly, 
however, antimicrobial activity of triclosan was retained when 
incorporated into silicone as previous demonstrated [27,28]. 
Not only did this material show antibacterial activity using 
agar diffusion and Live/Dead assays, but there was also long-
term (up to 11 weeks) persistence of antimicrobial activity.
It was initially envisaged that by incorporating a cylindrical 
section of this material into an existing Foley catheter, preven-
tion of catheter encrustation by P. mirabilis (introduced below 
the point of material insertion) would follow. Unfortunately, 
this was not evident and may have been due to the design of 
the ‘antimicrobial block’ or to urinary flow over the surface of 
the cylinder allowing P. mirabilis to bypass the intended anti-
microbial block. Significantly, however, use of triclosan within 
a dip coat silicone formulation resulted in a noticeable delay 
in catheter encrustation compared with controls. Indeed, over 
the 7-day period of running the in vitro bladder model, out of 
13 repeated experiments delayed encrustation occurred in 
all but one occasion compared to controls. Furthermore, on 
8 occasions there was no catheter blockage detected in any 
of the treated catheters over the duration of the experiment. 
Conclusion
Use of such a dip coat has a number of advantages. Theoretically, 
it would be applicable to all commercially available silicone 
catheters without the need for modification in catheter design 
and application to the inner and outer luminal surfaces would 
provide potential protection against both routes of bladder 
contamination. Further studies with the triclosan silicone 
formulation are still warranted, including those that investigate 
potential host cell toxicity and long-term benefits following its 
application to indwelling urinary catheters in clinical settings.
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